University of Illinois-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Illinois - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013503
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Illinois (UOL) is a university that offers undergraduate, graduate, and professional programs. The university offers online and continuing education programs such as undergraduate and graduate online degrees. It provides research activities in the areas of alternative, complementary and traditional medicine; biotechnology and biodefense; cancer biology and therapeutics; drug discovery, development and delivery; infectious diseases; natural products; neuroscience; patient safety; and pharmacoeconomics. The university offers courses through the College of Agricultural, Consumer and Environmental Sciences; College of Applied Health Sciences; Institute of Aviation; College of Business; College of Education; College of Engineering; and College of Fine and Applied Arts, among others. UOL is headquartered in Urbana, Illinois, the US.

University of Illinois – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Illinois, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Illinois, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Illinois, Medical Devices Deals, 2011 to YTD 2017 9
University of Illinois, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Illinois, Pharmaceuticals & Healthcare, Deal Details 12
Licensing Agreements 12
Revivo Therapeutics Receives Technology Rights from University of Illinois and Queens University 12
Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 13
Ocugen Enters into Licensing Agreement with University of Illinois at Chicago 14
Revolution Medicines Enters into Licensing Agreement with University of Illinois 15
Cortex Pharma Enters into Licensing Agreement with University of Illinois 16
zuChem Enters Into Licensing Agreement With University Of Illinois At Urbana-Champaign 17
University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 18
Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 19
Vanquish Oncology Enters into Licensing Agreement with University Of Illinois at Urbana-Champaign 20
AllyChem Enters Into Licensing Agreement With University of Illinois 21
Catylix Enters Into Licensing Agreement With The University Of Illinois At Urbana-Champaign 22
ImmuVen Enters Into Licensing Agreement With University Of Illinois 23
University of Illinois – Key Competitors 24
University of Illinois – Key Employees 25
University of Illinois – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Government and Public Interest 28
Nov 06, 2017: Stem cells from muscle could address diabetes-related circulation problems 28
Jul 17, 2017: Epilepsy biomarkers pave way for noninvasive diagnosis, better treatments 30
Feb 14, 2017: Tumor-targeting system uses cancer’s own mechanisms to betray its location 31
Oct 03, 2016: University of Illinois researchers quantify drug delivery from nanoparticles inside a cell 32
Jan 05, 2016: Lipoprotein nanoplatelets shed new light on biological molecules and cells 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
University of Illinois, Pharmaceuticals & Healthcare, Key Facts 2
University of Illinois, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Illinois, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Illinois, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Illinois, Deals By Therapy Area, 2011 to YTD 2017 8
University of Illinois, Medical Devices Deals, 2011 to YTD 2017 9
University of Illinois, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Revivo Therapeutics Receives Technology Rights from University of Illinois and Queens University 12
Actuate Therapeutics Enters into Licensing Agreement with University of Illinois at Chicago and Northwestern University 13
Ocugen Enters into Licensing Agreement with University of Illinois at Chicago 14
Revolution Medicines Enters into Licensing Agreement with University of Illinois 15
Cortex Pharma Enters into Licensing Agreement with University of Illinois 16
zuChem Enters Into Licensing Agreement With University Of Illinois At Urbana-Champaign 17
University Of Illinois And University Of Texas Enter Into Licensing Agreement With StemPar Sciences For Anti-Cancer Compounds 18
Sigma-Aldrich Enters Into Licensing Agreement With University of Illinois 19
Vanquish Oncology Enters into Licensing Agreement with University Of Illinois at Urbana-Champaign 20
AllyChem Enters Into Licensing Agreement With University of Illinois 21
Catylix Enters Into Licensing Agreement With The University Of Illinois At Urbana-Champaign 22
ImmuVen Enters Into Licensing Agreement With University Of Illinois 23
University of Illinois, Key Competitors 24
University of Illinois, Key Employees 25
University of Illinois, Subsidiaries 26

★海外企業調査レポート[University of Illinois-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Clearside BioMedical Inc (CLSD):製薬・医療:M&Aディール及び事業提携情報
    Summary Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO - Retinal Vein Occlu …
  • Aspen Technology Inc (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology Inc (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Take-Two Interactive Software, Inc.
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • BASF Corp-エネルギー分野:企業M&A・提携分析
    Summary BASF Corp (BASF), a subsidiary of BASF SE, is a chemical manufacturing company. Its product portfolio includes petrochemicals, monomers, intermediates, dispersions and pigments, care chemicals, nutrition and health products, paper chemicals, performance chemicals, catalysts, construction che …
  • Biodesy Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biodesy Inc (Biodesy) is a drug discovery company that develops and offers products for detecting conformational change in proteins and other biological molecules. The company provides products such as delta system, delta assay and screening kits, and delta software, among others. It also de …
  • Nanosonics Ltd (NAN)-医療機器分野:企業M&A・提携分析
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • Apollo Minerals Ltd:企業の戦略・SWOT・財務情報
    Apollo Minerals Ltd - Strategy, SWOT and Corporate Finance Report Summary Apollo Minerals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • T-Mobile US, Inc.:企業の戦略・SWOT・財務情報
    T-Mobile US, Inc. - Strategy, SWOT and Corporate Finance Report Summary T-Mobile US, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Charkit Chemical Company LLC:企業の戦略・SWOT・財務情報
    Charkit Chemical Company LLC - Strategy, SWOT and Corporate Finance Report Summary Charkit Chemical Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Public Power Corporation S.A.:企業の戦略・SWOT・財務情報
    Public Power Corporation S.A. - Strategy, SWOT and Corporate Finance Report Summary Public Power Corporation S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Envision Solar International Inc (EVSI):電力:M&Aディール及び事業提携情報
    Summary Envision Solar International Inc (Envision Solar) is a provider of energy security systems. The company's products include renewably energized electric vehicle charging systems, media and branding systems, energy security systems, patented solar tracking systems, energy storage systems, elec …
  • Baraka Energy & Resources Ltd (BKP):石油・ガス:M&Aディール及び事業提携情報
    Summary Baraka Energy & Resources Ltd (Baraka Energy), formerly Baraka Petroleum Ltd, is an oil and gas exploration and development company that offers oil and gas exploration and production services. The company explores, identifies, and develops energy and resource assets. It has oil and gas asset …
  • ArcDia International Oy Ltd:医療機器:M&Aディール及び事業提携情報
    Summary ArcDia International Oy Ltd (ArcDia International) is a healthcare service provider that offers vitro diagnostic services and develops products for the rapid testing of infectious diseases. The company's products include maripoc test system, an automated system for rapid multianalyte identif …
  • Globe Telecom Inc (GLO):企業の財務・戦略的SWOT分析
    Globe Telecom Inc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Burlington Stores, Inc.:企業の戦略・SWOT・財務分析
    Burlington Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Burlington Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Digirad Corp (DRAD)-医療機器分野:企業M&A・提携分析
    Summary Digirad Corp (Digirad) is a medical device company that offers mobile and on-site imaging solutions. The company offers camera products which include ergo, cardius x-ACT, cardius 2 XPO, corcam, quantumcam, and cardius 3 XPO. Its diagnostic services include nuclear cardiology, ultrasound, neu …
  • Ben E. Keith Co:企業の戦略的SWOT分析
    Ben E. Keith Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • The Walt Disney Company (DIS):企業の財務・戦略的SWOT分析
    The Walt Disney Company (DIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Zai Lab Ltd (ZLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Zai Lab Ltd (Zai Lab) is a biopharmaceutical company that discovers, develops and manufactures transformative medicines for cancer, autoimmune and infectious diseases. The company’s pipeline products include ZL-2306, ZL-2401, FPA144, EXT2514SUL, ZL-2301, ZL-3101, ZL-2302 and ZL-1101. It deve …
  • Bracco SpA:企業の戦略的SWOT分析
    Bracco SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆